Menu Search
Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Learn moreSubscribe now
Equities

Wai Yuen Tong Medicine Holdings Ltd

897:HKG.HS

Wai Yuen Tong Medicine Holdings Ltd

Actions
  • Price (HKD)0.202
  • Today's Change0.00 / 0.00%
  • Shares traded125.00k
  • 1 Year change+95.47%
  • Beta--
Data delayed at least 15 minutes, as of Nov 04 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Wai Yuen Tong Medicine Holdings Limited is a Hong Kong-based investment holding company principally engaged in the production and sales of pharmaceutical products. The Company operates through three segments. Production and Sale of Chinese Pharmaceutical and Health Food Products segment is mainly engaged in the manufacture, processing and retailing of traditional Chinese medicine in China and Hong Kong. Its products include Chinese medicines under the brand Wai Yuen Tong, as well as products manufactured with traditional prescriptions. Production and Sale of Western Pharmaceutical and Health Food Products segment is engaged in the processing and sales of Western pharmaceutical products and personal care products under the brands Madame Pearl’s and Pearl’s. Property Investment segment is engaged in the investment in commercial properties for rental income.

  • Revenue in HKD (TTM)783.88m
  • Net income in HKD-26.68m
  • Incorporated1994
  • Employees810.00
  • Location
    Wai Yuen Tong Medicine Holdings Ltd5th Floor, Wai Yuen Tong Medicine Bldng9 Wang Kwong RoadKowloon Bay, Kowloon Hong KongHKG
  • Phone+852 23128202
  • Fax+852 35266630
  • Websitehttps://www.wyth.net/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.